Clinical Trials Browser

Phase NA × camrelizumab × 1 year × Clear all

NCT07466901 2026-03-12

A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer

Phase NA Not yet recruiting

Uterine Cervical Neoplasms

NCT05772273 2025-11-21

PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute